Searchable abstracts of presentations at key conferences in endocrinology

ea0019p375 | Thyroid | SFEBES2009

Association of another member of the FCRL family with Graves' disease: further evidence for disrupted B cell signalling in disease pathogenesis

Simmonds M J , Newby P R , Franklyn J A , Gough S C L

Identifying the pathogenic pathways involved in complex diseases such as GravesÂ’ disease (GD) has proved challenging. Although several genetic risk factors, including the HLA class II region, CTLA4, PTPN22 and CD25, encode molecules playing key roles in antigen presentation and controlling T cell recognition/signalling, the identification of novel susceptibility loci has the potential to provide further insights into disease pathogenesis. Recently gen...